Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New antidiabetic agents from Ligand and Takeda

May 2, 2005

ZLB Behring to study C1-INH concentrate for hereditary angioedema

May 2, 2005

Hayashibara claims novel therapeutic agents for osteoporosis

April 29, 2005

One-year results of the RIO-Europe study support the use of rimonabant in obesity

April 29, 2005

Update on atosiban in the management of dysmenorrhea and preterm labor

April 29, 2005

New agents claimed for the treatment of lipoprotein disorders, obesity, etc.

April 29, 2005

Bentley and Dong Sung sign agreement for intranasal insulin in South Korea

April 29, 2005

Calpain: a potential target for the treatment of diabetic vascular complications

April 29, 2005

Preliminary data support the use of alglucosidase alfa in the treatment of Pompe disease

April 28, 2005

Asoprisnil found to prolong menstrual cycle in healthy premenopausal women

April 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...